ShuYu Civilian Pharmacy - Public Comps and Valuation Multiples

ShuYu Civilian Pharmacy Overview

About ShuYu Civilian Pharmacy

Shu Yu Civilian Pharmacy Corp Ltd is primarily involved in the operation and sales of Chinese and Western patent medicines, health foods, Chinese herbal medicines, health equipment and other products.

Founded

1999

HQ

Employees

n/a

Website

shuyupingmin.com

Sectors

Pharmacies

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$935M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

ShuYu Civilian Pharmacy Financials

ShuYu Civilian Pharmacy has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, ShuYu Civilian Pharmacy achieved revenue of $1.3B and an EBITDA of $111M.

ShuYu Civilian Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX

See ShuYu Civilian Pharmacy valuation multiples based on analyst estimates

ShuYu Civilian Pharmacy P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$1.3B	n/a	XXX	XXX	XXX
Gross Profit	$208M	$307M	XXX	XXX	XXX
Gross Margin	17%	NaN%	XXX	XXX	XXX
EBITDA	$111M	n/a	XXX	XXX	XXX
EBITDA Margin	9%	NaN%	XXX	XXX	XXX
Net Profit	$15.8M	$31.5M	XXX	XXX	XXX
Net Margin	1%	NaN%	XXX	XXX	XXX
Net Debt	$12.5M	$46.3M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

ShuYu Civilian Pharmacy Stock Performance

As of April 29, 2025, ShuYu Civilian Pharmacy's stock price is CNY 10 (or $1).

ShuYu Civilian Pharmacy has current market cap of CNY 4.2B (or $582M), and EV of CNY 6.8B (or $935M).

See ShuYu Civilian Pharmacy trading valuation data

ShuYu Civilian Pharmacy Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$935M	$582M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

ShuYu Civilian Pharmacy Valuation Multiples

As of April 29, 2025, ShuYu Civilian Pharmacy has market cap of $582M and EV of $935M.

ShuYu Civilian Pharmacy's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate ShuYu Civilian Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for ShuYu Civilian Pharmacy and 10K+ public comps

ShuYu Civilian Pharmacy Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$935M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	XXX	XXX
P/E	n/a	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get ShuYu Civilian Pharmacy Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

ShuYu Civilian Pharmacy Valuation Multiples

ShuYu Civilian Pharmacy's NTM/LTM revenue growth is n/a

ShuYu Civilian Pharmacy's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, ShuYu Civilian Pharmacy's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate ShuYu Civilian Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for ShuYu Civilian Pharmacy and other 10K+ public comps

ShuYu Civilian Pharmacy Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	n/a	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	3%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	1%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	25%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry